FDA Fast Tracks Novel siRNA Therapy for Preeclampsia Treatment
The investigational therapy is designed to decrease the production of soluble fms-like tyrosine kinase-1 (sFLT1) mRNA isoforms in the placenta.
The investigational therapy is designed to decrease the production of soluble fms-like tyrosine kinase-1 (sFLT1) mRNA isoforms in the placenta.
A review of the impact of oral estrogen therapy on risk for cardiovascular disease after menopause.
Zurzuvae is expected to become available in the fourth quarter of 2023 following scheduling as a controlled substance by the DEA.
Investigators evaluated differences in fertility rates and obstetric outcomes between women with vs without psoriasis.
In a systematic review, researchers determined the effects of different therapeutic physiotherapy modalities on insomnia and depression in women during perimenopause, menopause, and postmenopause.
Researchers sought to assess sex differences between men and women with atrial fibrillation and cognitive disease progression in mild cognitive impairment and dementia.
Investigators analyzed the effects of biologics on pregnancy outcomes in women with psoriasis.
Researchers sought to determine the relationship between pregnancy-induced hypertensive disorder and risk for heart failure.
Researchers examined retinal vascular changes among women who used oral contraceptive pills.
Fiona Watt, PhD, discusses findings of a review examining associations between changes in sex hormones with musculoskeletal pain and painful osteoarthritis. Credit: Getty Images